Percutaneous coronary intervention and atrial fibrillation: the triple therapy dilemma

被引：12

作者：

Cho, Jung Rae ^{[1
]}

Angiolillo, Dominick J. ^{[1
]}

机构：

[1] Univ Florida, Coll Med Jacksonville, Jacksonville, FL 32209 USA

来源：

JOURNAL OF THROMBOSIS AND THROMBOLYSIS | 2015年 / 39卷 / 02期

关键词：

PCI; Atrial fibrillation; Antithrombotic therapy; ELEVATION MYOCARDIAL-INFARCTION; ORAL ANTICOAGULANT-THERAPY; ANTITHROMBOTIC THERAPY; STENT IMPLANTATION; CONSENSUS DOCUMENT; WARFARIN; ASPIRIN; CLOPIDOGREL; MANAGEMENT; ANTIPLATELET;

D O I：

10.1007/s11239-014-1132-z

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atrial fibrillation (AF) represents the most common cardiac arrhythmia and chronic oral anticoagulation (OAC) is the cornerstone therapy to prevent cerebrovascular events among those having high thromboembolic risk. However, 20-30% of patients with AF have co-existing coronary artery disease (CAD). Importantly, since the prevalence of both AF and CAD increase with age, management of these patients has become an emerging clinical problem with the ever growing elderly population. In particular, many of these patients may develop an acute coronary syndrome (ACS) or require percutaneous coronary intervention (PCI), leading to the concomitant use of dual antiplatelet therapy (DAPT) including aspirin and a P2Y12 receptor inhibitor in addition to OAC, also known as triple antithrombotic therapy (TAT). However, TAT comes at the expense of an increased risk of bleeding complications. This viewpoint focuses on the current evidence of treatment, areas of unmet needs and future perspectives in the management of these high-risk patients.

引用

页码：203 / 208

页数：6

共 23 条

[1] Antiplatelet and Anticoagulant Therapy for Atherothrombotic Disease: The Role of Current and Emerging Agents [J].

Angiolillo, Dominick J. ;

Ferreiro, Jose Luis .

AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2013, 13 (04) :233-250

[2] Management of Antiplatelet and Anticoagulant Therapy in Patients With Atrial Fibrillation in the Setting of Acute Coronary Syndromes or Percutaneous Coronary Interventions [J].

Capodanno, Davide ;

Angiolillo, Dominick J. .

CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (01) :113-124

[3] Antithrombotic Therapy in the Elderly [J].

Capodanno, Davide ;

Angiolillo, Dominick J. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (21) :1683-1692

[4] Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial [J].

Connolly, S. ;

Pogue, J. ;

Hart, R. ;

Pfeffer, M. ;

Hohnloser, S. ;

Chrolavicius, S. ;

Yusuf, S. .

LANCET, 2006, 367 (9526) :1903-1912

[5] Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation [J].

Connolly, S. J. ;

Yusuf, S. ;

Camm, J. ;

Chrolavicius, S. ;

Commerford, P. ;

Flather, M. ;

Hart, R. G. ;

Hohnloser, S. H. ;

Joyner, C. ;

Pfeffer, M. ;

Gaudin, C. ;

Blumenthal, M. ;

Marchese, C. ;

Pogue, J. ;

Hart, R. ;

Hohnloser, S. ;

Anand, I. ;

Arthur, H. ;

Avezum, A. ;

Budaj, A. ;

Ceremuzynski, L. ;

De Caterina, R. ;

Diaz, R. ;

Dorian, P. ;

Flaker, G. ;

Fox, K. A. A. ;

Franzosi, M. G. ;

Goldhaber, S. ;

Golitsyn, S. ;

Granger, C. ;

Halon, D. ;

Hermosillo, A. ;

Hunt, D. ;

Jansky, P. ;

Karatzas, N. ;

Keltai, M. ;

Kozan, O. ;

Lanas, F. ;

Lau, P. ;

Le Heuzey, J. Y. ;

Lewis, B. S. ;

Morais, J. ;

Morillo, C. ;

Paolasso, E. ;

Peters, R. J. ;

Pfisterer, M. ;

Piegas, L. ;

Pipilis, A. ;

Sitkei, E. ;

Swedberg, K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (20) :2066-2078

[6] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Eikelboom, John ;

Oldgren, Jonas ;

Parekh, Amit ;

Pogue, Janice ;

Reilly, Paul A. ;

Themeles, Ellison ;

Varrone, Jeanne ;

Wang, Susan ;

Alings, Marco ;

Xavier, Denis ;

Zhu, Jun ;

Diaz, Rafael ;

Lewis, Basil S. ;

Darius, Harald ;

Diener, Hans-Christoph ;

Joyner, Campbell D. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151

[7] Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial [J].

Dewilde, Willem J. M. ;

Oirbans, Tom ;

Verheugt, Freek W. A. ;

Kelder, Johannes C. ;

De Smet, Bart J. G. L. ;

Herrman, Jean-Paul ;

Adriaenssens, Tom ;

Vrolix, Mathias ;

Heestermans, Antonius A. C. M. ;

Vis, Marije M. ;

Tijsen, Jan G. P. ;

van 't Hof, Arnoud W. ;

ten Berg, Jurrien M. .

LANCET, 2013, 381 (9872) :1107-1115

[8] Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting A North-American perspective [J].

Faxon, David P. ;

Eikelboom, John W. ;

Berger, Peter B. ;

Holmes, David R. ;

Bhatt, Deepak L. ;

Moliterno, David J. ;

Becker, Richard C. ;

Angiolillo, Dominick J. .

THROMBOSIS AND HAEMOSTASIS, 2011, 106 (04) :572-584

[9] Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting (ISAR-TRIPLE) study [J].

Fiedler, K. Anette ;

Byrne, Robert A. ;

Schulz, Stefanie ;

Sibbing, Dirk ;

Mehilli, Julinda ;

Ibrahim, Tareq ;

Maeng, Michael ;

Laugwitz, Karl-Ludwig ;

Kastrati, Adnan ;

Sarafoff, Nikolaus .

AMERICAN HEART JOURNAL, 2014, 167 (04) :459-U66

[10] Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy [J].

Fosbol, Emil L. ;

Wang, Tracy Y. ;

Li, Shuang ;

Piccini, Jonathan ;

Lopes, Renato D. ;

Mills, Roger M. ;

Klaskala, Winslow ;

Thomas, Laine ;

Roe, Matthew T. ;

Peterson, Eric D. .

AMERICAN HEART JOURNAL, 2013, 166 (05) :864-870

← 1 2 3 →